Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
Roche heads to FDA with Gazyva results in a form of lupus
5 months ago
Kura's AML drug passes key study in advanced patients, plans next steps with FDA and newly diagnosed studies
5 months ago
Small personalized vaccine trial sees progress in late-stage kidney cancer
5 months ago
EyePoint shares more mid-stage data for therapy trying to compete with Regeneron's Eylea
5 months ago
Pharma
Amgen announces hold on Phase 1 obesity candidate, pipeline cuts
5 months ago
Pharma
After relaunch, Roche gets FDA approval for ocular implant in diabetic macular edema
5 months ago
FDA+
New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug
5 months ago
Gene-edited pig kidneys to be tested in more humans soon, two companies say
5 months ago
Biogen’s revised research strategy is to avoid becoming obsolete, top exec says
5 months ago
Deals
China
Irish startup reports mid-stage victory for short-acting psychedelic drug in depression
5 months ago
Drugmakers seize on biomarkers to test the FDA's rare disease shift
5 months ago
FDA+
In Focus
Exclusive: German biotech declares Phase 2 win for non-opioid drug for neuropathic pain
5 months ago
Daiichi Sankyo taps new CEO, aims to build up ADC franchise
5 months ago
People
Cargo Therapeutics cuts lead CAR-T program, 50% of staff
5 months ago
People
Cell/Gene Tx
Tectonic gets Phase 1b win in heart condition where Eli Lilly recently failed
5 months ago
Merck stops another Winrevair study early based on positive results from earlier PAH trial
5 months ago
Roche aims for derisked deals and ruthless portfolio cuts in 2025
5 months ago
Deals
Inhibikase shelves Parkinson’s asset after Phase 2 flop
5 months ago
Exclusive: Fertility startup to begin Phase 3 study of stem cell therapy for IVF
5 months ago
FDA+
Ahead of earnings, Lilly culls mid-stage drug for heart failure and chronic kidney disease
5 months ago
Pharma
Leap Therapeutics treks toward pivotal study in colorectal cancer, drops gastric cancer
5 months ago
ITM aims to compete with Novartis after Phase 3 radiopharma win
5 months ago
Sarepta shares two-year DMD study data that could inform European approval decision
5 months ago
Pharma
FDA+
Bristol Myers shares IO combo data in colorectal cancer; Pfizer still waiting on Braftovi regimen survival figures
5 months ago
Pharma
First page
Previous page
14
15
16
17
18
19
20
Next page
Last page